Alternatives to AquaBounty Technologies

Develops novel oral RNA delivery platforms for aquaculture health management, focusing on disease resistance.

Converts invasive shore crabs into sustainable protein and lipid ingredients for the feed industry.

Pioneering sustainable oils and fats through fermentation.

Cultivation facility specializing in commercial production of natural, wildtype microalgae species for aquaculture.

Enzyme-based technology to break down alcohol in the stomach.

Biotechnology startup using genetically engineered insects to convert organic waste into high-value recombinant proteins.

Develops nanostructured sensor chips for rapid pathogen identification in food.

Develops and commercializes biological solutions for pest control in plant, home, and public health sectors.

Developing disease-resistant crops using AI-driven platform to resurrect native resistance mechanisms.

UK biotechnology company developing sustainable natural rubber from engineered dandelions.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Gavan Technologies offers Fatrix, a next-generation fat system designed to provide indulgence without compromise in food products.

Sustainable insect farming solutions providing Black Soldier Fly eggs and neonates globally.

Developing vegan cheese that mimics the taste, feel, and cost of dairy cheese.

Innovating resilient crop seeds using gene-editing technology to combat climate change impacts.

AI safety and research company building reliable, interpretable, and steerable AI systems.

Developing zero-waste fish farms using advanced aquaculture wastewater management and off-flavor mitigation.

FoodTech startup using natural enzymes to reduce sugar in juices by 30-80%.

Bosque Foods creates nutrient-dense, clean-label whole-cut meat alternatives from mycelium, the root structure of mushrooms.

Global biopharmaceutical company pioneering mRNA-based immunotherapies and vaccines for cancer and infectious diseases.

Biotechnology company developing and commercializing cell therapies for cancer treatment.

Global venture capital firm backing ambitious entrepreneurs from seed to IPO across technology and life sciences.

Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology.

Biotechnology company leveraging ultracompact CRISPR systems for gene editing therapies and diagnostics.

Clinical-stage biotechnology company developing autologous neuron replacement medicines for neurodegenerative disorders.

Sustainable seafood platform balancing delicious fish consumption with marine habitat protection.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Developing novel therapeutics to restore gut lymphatic function.

Clinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.

Spatial multiomics company developing technologies for single-cell gene expression profiling in intact tissues.

Global supplier of life science research tools, including antibodies, reagents, and assays.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

Developing first-and best-in-class antibody-drug conjugates (ADCs) for cancers with high unmet medical need.

Biopharmaceutical company developing and commercializing CNS disease treatments.

Clinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.

A vertically-integrated procurement platform for the life sciences industry.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

Biopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

A global leader in clinical pharmacology and bioanalytical sciences.

A leading organization dedicated to curing and treating cystic fibrosis.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.

Developing novel immunotherapies and diagnostics for cancer.

BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.

A clinical-stage biopharmaceutical company developing novel therapies for neurological disorders.

AI-powered precision testing for patient identification in clinics and clinical trials.

A biotechnology company developing genetic therapies for rare disorders.

A clinical-stage biotechnology company developing in vivo gene editing therapies.

Accelerating patient access to evidence-based innovation in mental health.

A clinical-stage biopharmaceutical company developing novel immunotherapies.

Developing gene editing therapies to lower cholesterol.

A life sciences company that has developed a high-throughput platform for mapping molecular cell architecture at nanoscale resolution.

A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.

Developing TCR-mimetic antibody therapies to treat cancer by targeting peptide-loaded major histocompatibility complexes.